Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study-Reference-Cited by-同舟云学术

Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study

Published:2021-12-03 Issue: Volume: Page:
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

López Montesinos Inmaculada^ORCID,Gómez-Zorrilla Silvia,Palacios-Baena Zaira Raquel,Prim Nuria,Echeverria-Esnal Daniel,Gracia María Pilar,Montero María Milagro,Durán-Jordà Xavier,Sendra Elena,Sorli Luisa,Guerri-Fernandez Roberto,Padilla Eduardo,Grau Santiago,Horcajada Juan Pablo,

Funder

Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-021-00570-z.pdf

Reference41 articles.

1. Horcajada JP, Montero M, Oliver A, et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev. 2019;32:e00031–19. http://cmr.asm.org/content/32/4/e00031-19.abstract.

2. Oliver A, Mulet X, López-Causapé C, Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat. 2015;21–22:41–59. https://doi.org/10.1016/j.drup.2015.08.002.

3. Lamas Ferreiro JL, Álvarez Otero J, González González L, et al. Pseudomonas aeruginosa urinary tract infections in hospitalized patients: mortality and prognostic factors. PLoS ONE. 2017;12:e0178178. https://doi.org/10.1371/journal.pone.0178178.